BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21033219)

  • 1. Expression of p16, p53, and Ki-67 in colorectal adenocarcinoma: a study of 356 surgically resected cases.
    Huh JW; Lee JH; Kim HR
    Hepatogastroenterology; 2010; 57(101):734-40. PubMed ID: 21033219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
    Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
    Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis.
    Hoos A; Nissan A; Stojadinovic A; Shia J; Hedvat CV; Leung DH; Paty PB; Klimstra D; Cordon-Cardo C; Wong WD
    Clin Cancer Res; 2002 Dec; 8(12):3841-9. PubMed ID: 12473598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
    Cai S; Han K
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
    J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
    Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
    J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
    Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
    Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors.
    Buchynska LG; Nesina IP; Yurchenko NP; Bilyk OO; Grinkevych VN; Svintitsky VS
    Exp Oncol; 2007 Mar; 29(1):49-53. PubMed ID: 17431389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic significance of P53 protein expression in patients with colorectal adenocarcinoma].
    Wang Q; Zhao P; Hu Y; Yang G
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):182-4. PubMed ID: 10684011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of regulatory proteins and proliferative activity in relation to phenotypic characteristics of upper urothelial carcinoma.
    Dolićanin Z; Velicković LJ; Djordjević B; Visnjić M; Pesić I; Ristić A; Marjanović V
    Vojnosanit Pregl; 2011 Jul; 68(7):567-74. PubMed ID: 21899177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 inactivation in small-sized lung adenocarcinoma: its association with poor prognosis.
    Kawabuchi B; Moriyama S; Hironaka M; Fujii T; Koike M; Moriyama H; Nishimura Y; Mizuno S; Fukayama M
    Int J Cancer; 1999 Feb; 84(1):49-53. PubMed ID: 9988232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical investigation of P16, P53 and Ki-67's prognostic values in diffuse large B-Cell lymphomas.
    Baran M; Canoz O; Altuntas H; Sivgin S; Cetin M; Yay A; Ketenci S
    Bratisl Lek Listy; 2017; 118(10):602-608. PubMed ID: 29198127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression.
    Lam AK; Ong K; Ho YH
    Dis Colon Rectum; 2006 Sep; 49(9):1275-83. PubMed ID: 16912910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
    Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
    World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
    Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
    Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas.
    Shimizu M; Nikaido T; Toki T; Shiozawa T; Fujii S
    Cancer; 1999 Feb; 85(3):669-77. PubMed ID: 10091740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases.
    Chaux A; Pfannl R; Rodríguez IM; Barreto JE; Velazquez EF; Lezcano C; Piris A; Netto GJ; Cubilla AL
    Am J Surg Pathol; 2011 Apr; 35(4):553-62. PubMed ID: 21399489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.